Pharmaceutical Carrier’s for Topical Drug Delivery System
Beginning with a revenue breakdown of this specific market, this study seeks to describe the intricate world of drug carriers. A quick introduction of various different types of traditional and cutting-edge drug carrier systems is provided in the section that follows.Avariety of topical active substances, such as sunscreen ingredients, corticosteroids, and antibacterial, antifungal, and antiviral agents, can be delivered via foam technology. Ointments are semisolids used for external skin or mucous membrane treatment. Less than 20% of them often contain water and volatiles. Targeted medication delivery to and through the skin has a lot of potential using nano systems like micro emulsions and nano emulsions. By lowering surface and inter facial tension and increasing the viscosity of the aqueous phase, nanoemulgel improves a stable nano emulsion formulation. The various carrier types that the authors used in their formulation and conclusion have been added as a final effort for this work, highlighting the need to establish a strong double link between the newly developed industrial processes and the flexibility of medication delivery systems that is so desperately neededfor use with people.
2. Burbank KM, Steven GS, Robert ADL, Joseph CW. Early application of topical antibiotic powder in open-fracture wounds: A strategy to prevent biofilm formation and infections. OTA Int.2020; 3(4):1-6
3. Martins AT, Oliveira AC, Robles Velasco MV,Arilmí rosa G.G, Cosquillo rafael MF, Jossimar Paul HT, Mónica GR. Contribution of topical antioxidants to maintain healthy skin. A review. Sci. Pharm. 2020; 88(2):2-17.
4. Bhuyan C, Dipankar S,Rabha B. A brief review on topical gels as drug delivery system. Journalof pharmaceutical research international.2021; 33(47):345-357.
5. Mendonsa NS, Pradhan A, Sharma P, Rosa M B P,Narasimha MurthyS,Kundu S, Michael. A quality by design approach to develop topical creams via hot-melt extrusion technology. Journal of pharmacy and technology. Eur J Pharm Sci. 2019:2-25.
6. Ueda CT, Vinod PS, Kris D, Ewing G, Flynn G,Marques M, Howard R, Steve S, Kailas T,Yacobi A. Topical and transdermal drug products. The topical/transdermal ad hoc advisory panel for the USP performance testsof topical and transdermal dosage forms:Pharmacopeial Forum.2009;35(3):751-763.
7. Zhao Y, Jones SA, Brown MB. Dynamic foams in topical drug delivery. Journal of Pharmacy and pharmacology.2010; 62(6):679-684.
8. Benson HAE, Grice JE, Yousuf M, Sarika N, Roberts MS.Topical and transdermal drug delivery: from simple portions to smart technologies. CurrDrugDeliv. 2019; 16(5):444-460.
9. Tiwaria S, Goyalb AK, Mishraa N, Bhuvaneshwar V, Abhinav M, Devyani D, Suresh P.V. Liposome in situ gelling system: Novel carrierbased vaccine adjuvant for intranasal delivery of recombinant protein vaccine. Elsevier Procedia in Vaccinology.2009; 1(1):148-163.
10. KrishnanY,Mitragotri S.Nanoparticles for topical drug delivery: Potential for skin cancer treatment national library of medicine. Advanced drug delivery reviews.2020; 153(1):87-108.
11. Selvamuthukumar S, Krishnamoorthy K,Rajappan M. Nanosponges: a novel class of drug delivery systemreview.JPPS.2012;15(1)103-111.
12. Architha AP, Vinayak k, Khalandar RM, Shabaraya AR. Formulation and evaluation of nanosponge based topical gel preparation of dapsone. Research gate poster presentation.2019.
13. Rajan R, Jose S, Mukund VP, Vasudevan DT. Transferosomes – A vesicular transdermal delivery system for enhanced drug permeation, J Adv Pharm technol res. 2011; 2(3):138-143.
14. ZhaoY,Jones SA, Brown MB. Dynamic foams in topical drug delivery, Pharm Pharmacol, 2010; 62(6):78-84.
15. Benson HAE, Grice JE,Yousuf M, Namjoshi S, Roberts MS. Topical and transdermal drug delivery: from simple potions to smart technologies. CurrDrugDeliv. 2019;16(5):444-460
16. Burbank KM,Schauer SG, De lorenzo RA,Joseph CW. Early application of topical antibiotic powder in open-fracture wounds: A strategy to prevent biofilm formation and infections, OTA Int 2020; 3(4):145-182.
17. Torchilin V, Weissig V. Liposomes: A Practical Approach. Oxford University Press; Kettering, UK: 2003. 77–101.
18. Kumar I, Sunny D, Priyankul P, Pankaj Kumar, Nishant Sharma. Dendrimers: Potential Drug Carrier For Novel Drug Delivery System. Asian Journal of Pharmaceutical Research and Development. 2021; 9(2): 70-79
19. Mandeep M, Raj K.S.B, Deborah L. Development of a novel polymer- based carrier for deformable liposomes for the controlled dermal delivery of naringenin. Journal of liposome research.2022;32(2):181-194.
20. Lamsal R, Geethalakshmi A, Gubbala S. formulation and evaluation of gliclaide ethosomws as a novel drug carrier.IJPSR.2015;6(5):2072-2080.
21. Thakur N, Jain P, vivek J. formulation development and evaluation of transferosomal gel.JDDT.2018; 8(5):168-177.
22. Laxmi M, Bhardwaj A, Mehta S, Abhinav M. development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether. artifical cells,nanomedicine and biotechnology.2015; 43(5)334-344.
23. Jagusiak A, Chlopas K, Zemanek G, Wolski P, Tomasz P. Controlled Release of Doxorubicin from the Drug Delivery Formulation composed of single-walled carbon nanotubes and cango red: a molecular dynamics study and dynamic light scattering analysis. Pharmaceutics.2020; 12(7):622.
24. Raj kumar D, Sahu S. development of oxaliplatin encapsulated in magnetic nanocarriers of pectin as a potential targeted drug delivery for cancer therapy.ELSEVIER.2012:2(2); 38-45.
25. Koli AR, Ranch KM, Patel HP, Parikh RK, Shah DO, Maulvi FA. Oral bioavailability improvement of felodipine using tailored microemulsion: Surface science, ex vivo and in vivo studies.Int J Pharm. 2021; 596(1).
26. Abhisek N, Roshan I,Khinchi M.P. Microsphere as a novel drug delivery system: a review. Asian Journal of Pharmaceutical Research and Development. 2015.3(1):15-24
27. Chauhan AS, Sridevi S, Kishore BC, Jain AK, Sanjay KJ, Jain NK, Prakash VD.Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J Control Release. 2003; 90(3):335-43.
28. Krishna K, Manoj kumar M,Srivastava R.Fabrication and characterization of pluronic F68 and phospholipon 90g embedded nanoformulation for sertraline delivery: An optimized factorial design approach and in vivostudy.Asian Journal ofPharmaceutical Research and Development. 2019; 7(3):59-66.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).